The Gestational Diabetes Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Gestational Diabetes Market?
The Gestational Diabetes Global Market Report 2025 market has demonstrated substantial enlargement in recent years. The market size escalated from $8.37 billion in 2024 to $9.14 billion in 2025, marking an impressive compound annual growth rate of 9.3%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Gestational Diabetes Industry?
The Gestational Diabetes Global Market is expected to grow to $12.90 billion by 2029, with a compound annual growth rate (CAGR) of 9.0%.
Download Your Free Sample of the 2025 Gestational Diabetes Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Gestational Diabetes Market?
The key drivers in the gestational diabetes market are:
•Higher rates of obesity contributing to an increase in gestational diabetes
•Growing acceptance and use of cloud-based projects, devices, and apps for medical management
•Rise in unhealthy lifestyles leading to increased prevalence of diabetes
•Growing public health consciousness aiding in disease prevention and management
Global Market Segmentation: Identifying Major Gestational Diabetes Industry Segments
The gestational diabetes market covered in this report is segmented –
1) By Types: Type A1, Type A2, Other Types
2) By Treatment: Monitoring, Drug Treatment, Non-pharmacological treatment
3) By Administration: Oral, Intravenous, Other Administrations
4) By End User: Hospitals, Clinics, Home Care Settings, Diagnostic Centers
Subsegments:
1) By Type A1: Diet-Controlled Gestational Diabetes, Exercise-Controlled Gestational Diabetes
2) By Type A2: Insulin-Controlled Gestational Diabetes, Oral Medication-Controlled Gestational Diabetes
3) By Other Types: Pre-Gestational Diabetes, Gestational Diabetes With Complications
Pre-order the 2025 Gestational Diabetes Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Gestational Diabetes Market?
The key trends in the gestational diabetes market are:
•The gestational diabetes market is showing a trend towards digital diabetes management apps.
•The introduction and use of closed-loop control systems is an emerging trend in this market.
•Innovative medical technologies are shaping the future of the gestational diabetes market.
•Enzymatic technology is becoming increasingly prevalent in the gestational diabetes market.
Who Are the Top Competitors & Leading Players in the Gestational Diabetes Market?
Major players in the gestational diabetes market are:
• Sanofi S.A.
• AstraZeneca plc
• Abbott Laboratories
• Eli Lilly and Company
• Novo Nordisk A/S
• Becton, Dickinson and Company
• Boehringer Ingelheim GmbH
• Dexcom Inc
• Biocon Limited
• LifeScan Inc
• Ascensia Diabetes Care Holdings AG
• Trividia Health Inc.
• Nipro Diagnostics, Inc.
• Sernova Corp.
• ZyVersa Therapeutics, Inc.
• Peptron Inc.
• Roche Diabetes Care
• DiabetOmics Inc
• Merck & Co. Inc.
• Medtronic plc
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the gestational diabetes market in 2024
